Recent Updates
Recently added Catalysts
BBIO Positive Sentiment Score: 70/100

BridgeBio Pharma to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

Thursday, September 7, 2023 1 min read
Key Takeaway: BridgeBio Pharma, a company specializing in genetic diseases and cancers, is set to present at the Morgan Stanley 21st Annual Global Healthcare Conference in New York. The presentation is scheduled for September 12, 2023, at 10:50 am ET. Interested parties can access the live webcast on the company's website, with a replay available for 90 days post-event. This participation underscores BridgeBio's efforts to engage with investors and stakeholders in the healthcare sector.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a major healthcare conference enhances visibility.
  • Opportunity to showcase innovations in genetic diseases and cancers.
  • Live webcast allows for broader accessibility to stakeholders.

Full Press Release Details

PALO ALTO, Calif., Sept. 07, 2023 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced that members of its management team will present at the Morgan Stanley 21st Annual Global Healthcare Conference in New York, NY on Tuesday, September 12 at 10:50 am ET.
To access the live webcast of BridgeBio’s presentation, please visit the “Events & Presentations” page within the Investors section of the BridgeBio website at http://investor.bridgebio.com. A replay of the webcast will be available on the BridgeBio website for 90 days following the event.
About BridgeBio Pharma, Inc.
contact@bridgebio.com

Frequently Asked Questions

When will BridgeBio present at the Morgan Stanley Conference?

BridgeBio will present on September 12, 2023, at 10:50 am ET.

How can I watch the BridgeBio presentation live?

You can access the live webcast on the BridgeBio 'Events & Presentations' page.

Where can I find the replay of the webcast?

The webcast replay will be available on the BridgeBio website for 90 days.

What is BridgeBio Pharma focused on?

BridgeBio specializes in genetic diseases and cancers.

What is BridgeBio's stock symbol?

BridgeBio trades under the Nasdaq symbol BBIO.

Tags: BBIO Viatris Investor Conferences Healthcare BridgeBio Morgan Stanley healthcare conference biopharmaceuticals genetic diseases
Last updated: Sep 7, 2023